Tag : azacitidine

Latest News

Samenvatting: Takeda kondigt overtuigende gegevens aan van de fase 2-studie met Pevonedistat Plus Azacitidine bij patiënten met MDS met een hoger risico

Newsemia
CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502 / NYSE: TAK) heeft vandaag aangekondigd dat de resultaten van de fase 2 Pevonedistat-2001-studie...
Latest News

Takeda publie des données probantes de son essai de Phase 2 sur l’association pevonedistat plus azacitidine administrée à des patients souffrant de SMD à haut risque

Newsemia
CAMBRIDGE, Massachusetts, et OSAKA, Japon–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) a annoncé aujourd’hui que les résultats de l’essai Pevonedistat-2001 de Phase 2 seront présentés dans...
Pharma / Biotech

Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model.

Newsemia
Related Articles Oral Azacitidine and Cedazuridine Approximate Parenteral Azacitidine Efficacy in Murine Model. Target Oncol. 2020 Mar 28;: Authors: Ramsey HE, Oganesian A, Gorska AE,...
Pharma / Biotech

Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer.

Newsemia
Related Articles Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer. Cancer Chemother Pharmacol....
Pharma / Biotech

Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma.

Newsemia
Related Articles Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma. Eur J Cancer. 2019 Nov...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy